BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feldman C, Anderson R. Meningococcal pneumonia: a review. Pneumonia (Nathan) 2019;11:3. [PMID: 31463180 DOI: 10.1186/s41479-019-0062-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Taha MK, Deghmane AE. Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease. BMC Res Notes 2020;13:399. [PMID: 32854773 DOI: 10.1186/s13104-020-05241-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
2 Murali S, Marks A, Heeger A, Dako F, Febbo J. Pneumonia in the Immunocompromised Host. Seminars in Roentgenology 2022;57:90-104. [DOI: 10.1053/j.ro.2021.10.009] [Reference Citation Analysis]
3 Taha MK, Martinon-Torres F, Köllges R, Bonanni P, Safadi MAP, Booy R, Smith V, Garcia S, Bekkat-Berkani R, Abitbol V. Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease. Expert Rev Vaccines 2022. [PMID: 35271781 DOI: 10.1080/14760584.2022.2052048] [Reference Citation Analysis]
4 Weil-Olivier C, Taha MK, Emery C, Bouée S, Beck E, Aris E, Loncle-Provot V, Nachbaur G, Pribil C. Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database. Infect Dis Ther 2021;10:1607-23. [PMID: 34170505 DOI: 10.1007/s40121-021-00468-w] [Reference Citation Analysis]
5 Centanni AV, Harris C, Taghavi S. A Rare Case of Neisseria Meningitidis Pneumonia in a Polytrauma Patient. Am Surg 2020;:3134820940283. [PMID: 32735451 DOI: 10.1177/0003134820940283] [Reference Citation Analysis]
6 Deghmane AE, Taha S, Taha MK. Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review. Infect Dis (Lond) 2022;54:1-7. [PMID: 34459329 DOI: 10.1080/23744235.2021.1971289] [Reference Citation Analysis]
7 Ludwig H, Boccadoro M, Moreau P, San-Miguel J, Cavo M, Pawlyn C, Zweegman S, Facon T, Driessen C, Hajek R, Dimopoulos MA, Gay F, Avet-Loiseau H, Terpos E, Zojer N, Mohty M, Mateos MV, Einsele H, Delforge M, Caers J, Weisel K, Jackson G, Garderet L, Engelhardt M, van de Donk N, Leleu X, Goldschmidt H, Beksac M, Nijhof I, Abildgaard N, Bringhen S, Sonneveld P. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. Leukemia 2021;35:31-44. [PMID: 32814840 DOI: 10.1038/s41375-020-01016-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
8 Taha MK, Gaudelus J, Deghmane AE, Caron F. Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries. Hum Vaccin Immunother 2020;16:2518-23. [PMID: 32209010 DOI: 10.1080/21645515.2020.1729030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Farraj SA, El-Kafrawy SA, Kumosani TA, Yousef JM, Azhar EI. Evaluation of Extraction Methods for Clinical Metagenomic Assay. Microorganisms 2020;8:E1128. [PMID: 32727010 DOI: 10.3390/microorganisms8081128] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Smaoui H, Tali-Maamar H, Zouhair S, Bouheraoua S, Mefteh K, Bouskraoui M, Amiche A, Khris M, Deghmane AE, Taha MK; Study group. Implementation of a prospective study for enhancing surveillance of invasive bacterial infections in North Africa. Int J Infect Dis 2021;115:101-5. [PMID: 34843957 DOI: 10.1016/j.ijid.2021.11.036] [Reference Citation Analysis]
11 Weil-Olivier C, Taha MK, Bouée S, Emery C, Loncle-Provot V, Nachbaur G, Beck E, Pribil C. Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database. Hum Vaccin Immunother 2022;:1-11. [PMID: 35192785 DOI: 10.1080/21645515.2021.2021764] [Reference Citation Analysis]
12 Taha MK, Weil-Olivier C, Bouée S, Emery C, Nachbaur G, Pribil C, Loncle-Provot V. Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database. Hum Vaccin Immunother 2021;17:1858-66. [PMID: 33449835 DOI: 10.1080/21645515.2020.1849518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Landová B, Šilhán J. Conformational changes of DNA repair glycosylase MutM triggered by DNA binding. FEBS Lett 2020;594:3032-44. [PMID: 32598485 DOI: 10.1002/1873-3468.13876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]